Key Players of Ophthalmology Amniotic Membrane Market

Key Players of Ophthalmology Amniotic Membrane Market

The company is a leader in producing placental based products and has over 40 scientific and clinical publications. DataM Intelligence

2021-08-26

Key Player involved in Ophthalmology Amniotic Membrane Market

MiMedx Group, Inc., 

  • MiMedx Group, Inc., headquartered in Marietta, Georgia, is a biopharmaceutical company specialized in developing, manufacturing, and marketing regenerative biologics utilizing human placental allografts for multiple operative sectors of healthcare
  • The Company manufactures human placental tissue via its proprietary PURION process methodology, to manufacture safe and effective amnion allografts via aseptic processing techniques along with terminal sterilization
  • The company is a leader in producing placental-based products and has over 40 scientific and clinical publications
  • MiMedx has over 45 placental tissues issued and allowed patents on their amniotic membrane-based products and technologies, with over 90 pending applications

Skye Biologics Inc.

  • The company is engaged in the development and manufacture of Extracellular Matrix Biologic (BioECM) products that are designed to engage and assist the body to restore damaged connective tissues
  • The amniotic membrane products offered by the company have been used in over 200,000 tissue-repair treatments nationwide, to augment degenerated tissues in surgical repairs and non-operative therapies
  • The company’s amniotic products find major applications in the treatment of musculoskeletal injuries, nerve grafting, scar, and adhesion prevention, wound repair, and Opthalmology. 
  • The company offers biologics derived from the human placenta for application in orthopedic, podiatry, Neuro and spine, GYN, urologic, colorectal, general, head, and neck, ocular, and wound care procedures

Katena Products, Inc. 

  • Katena Products, Inc. is the largest independently owned American company dedicated exclusively to ophthalmic surgical instrumentation
  • Katana offers its products to over 7,000 customers in the United States and, through a global network of distributors, to customers in more than 100 countries around the world
  • The company operates in four business segments including Surgical instruments, Biologics, Ophthalmic Devices, and Lenses
  • The popular product brands of the company for amniotic membranes are AmbioDisk and AmbioSurg
  • The company has maintained its quality standards while expanding its product portfolio to include biologics, diagnostic lenses, punctum plugs, and devices for glaucoma and corneal surgery
  • The company strengthened its product reach through its distribution network and has product penetration in over 110 countries
  • It serves both surgeons and patients in advancing ocular health and ophthalmic surgical outcomes

TissueTech, Inc., 

  • TissueTech, Inc., operates as a parent company of Amniox Medical, Inc. and BioTissue(R), Inc., which pioneered the development and clinical application of amniotic tissue-based products
  • Amniox Medical, a subsidiary of Tissue-Tech is focused on developing and marketing products for use in the musculoskeletal and wound care markets
  • The company, Tissue-Tech is receiving research grants from the National Institutes of Health (NIH) for over 30 years
  • More than 300,000 human implants of the company's amniotic membrane products have been performed by the clinicians 
  • The Company's first product, AmnioGraft(R), is the only tissue graft designated by the FDA as homologous for promoting ophthalmic wound healing
  • The company’s subsidiaries areBio-Tissue, Inc., Amniox Medical, Inc.

Bio-Tissue

  • Bio-Tissue is a subsidiary of TissueTech, manufacturing regenerative medicine for ocular surface disease and injury, as well as ocular hygiene solutions for eye care professionals. 
  • The company serves an unmet need for better surgical and therapeutic alternatives for helping eye care professionals manage ocular surface conditions such as keratitis, recurrent corneal erosions, and conjunctivochalasis (CCh) also known as mechanical dry eye, pterygium, and severe dry eye.
  • Bio-Tissue develops amniotic membrane and umbilical cord products used by eye care professionals worldwide.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

Found it interesting?

Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866

We have 5000+ marketing reports and serve across 130+ countries